Extracorporeal membrane oxygenation for tuberculosis pneumonia with empyema

dc.contributor.authorBesa, Santiago
dc.contributor.authorMorales, Alvaro J.
dc.contributor.authorSalas, Patricio
dc.contributor.authorBravo M, Sebastian
dc.contributor.authorGarrido-Olivares, Luis
dc.date.accessioned2025-01-20T22:07:26Z
dc.date.available2025-01-20T22:07:26Z
dc.date.issued2021
dc.description.abstractAcute respiratory distress syndrome (ARDS) caused by Mycobacterium Tuberculosis (TB) is a rare entity. Extracorporeal membrane oxygenation (ECMO) therapy had been used as an effective therapy for this cases, but the evidence is scarce. We present a case that took place in the middle of SARS-CoV2 pandemic. A 33-year-old female presented with ARDS due to pulmonary TB infection (pneumonia with empyema and pneumothorax), which required invasive mechanical ventilation with poor response. Long term veno-arterio-venous (VAV) ECMO, overlapped with veno-venous ECMO, was used as a salvage therapy with a good response for a total of 26 days. This is an example of the effectiveness of this therapy in this scenario, never described before. The fact that this therapy was used in the middle of SARS-CoV2 pandemic, with limited resources available, was remarkable, but it was encouraged by previous successful experiences.
dc.fuente.origenWOS
dc.identifier.doi10.1016/j.rmcr.2021.101481
dc.identifier.issn2213-0071
dc.identifier.urihttps://doi.org/10.1016/j.rmcr.2021.101481
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/94240
dc.identifier.wosidWOS:000702416000013
dc.language.isoen
dc.revistaRespiratory medicine case reports
dc.rightsacceso restringido
dc.subjectECMO
dc.subjectAcute respiratory failure
dc.subjectTuberculosis
dc.subjectEmpyema
dc.subject.ods03 Good Health and Well-being
dc.subject.odspa03 Salud y bienestar
dc.titleExtracorporeal membrane oxygenation for tuberculosis pneumonia with empyema
dc.typeartículo
dc.volumen34
sipa.indexWOS
sipa.trazabilidadWOS;2025-01-12
Files